BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1762312)

  • 1. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients.
    Boero R; Degli Esposti E; Fabbri A; Guarena C; Forneris G; Quarello F; Fusaroli M; Piccoli G
    Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy.
    Boero R; Fabbri A; Degli Esposti E; Guarena C; Forneris G; Lucatello A; Sturani A; Quarello F; Fusaroli M; Piccoli G
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):61-5. PubMed ID: 8494021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of red cell sodium-lithium countertransport in hyperlipidemias.
    Corrocher R; Steinmayr M; Ruzzenente O; Brugnara C; Bertinato L; Mazzi M; Furri C; Bonfanti F; De Sandre G
    Life Sci; 1985 Feb; 36(7):649-55. PubMed ID: 3968981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of erythrocyte sodium/lithium countertransport activity in families of patients with immunoglobulin A nephropathy.
    Fabbri A; Boero R; Degli Esposti E; Guarena C; Lucatello A; Sturani A; Piccoli G; Fusaroli M
    Clin Sci (Lond); 1992 Aug; 83(2):241-5. PubMed ID: 1327641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
    Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Red-cell sodium-lithium countertransport in patients with IgA nephrology and renal hypertension].
    Chen YD; Zheng FL; Wen LR
    Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):214-7, 254. PubMed ID: 7922761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients.
    Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG
    Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-lithium countertransport kinetics in IgA nephropathy: relation to plasma lipids and renal impairment.
    Ho KK; Thomas TH; Rutherford PA; Wilkinson R
    Nephron; 1995; 69(4):391-6. PubMed ID: 7777102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension.
    Weder AB; Fitzpatrick MA; Torretti BA; Hinderliter AL; Egan BM; Julius S
    Hypertension; 1987 May; 9(5):459-66. PubMed ID: 3570422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixture analysis of erythrocyte lithium-sodium countertransport and blood pressure.
    Weder AB; Schork NJ
    Hypertension; 1989 Feb; 13(2):145-50. PubMed ID: 2914736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
    Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte Na,Li countertransport and arterial pressure in diabetic adolescents.
    Dianzani I; Boero R; Rolando B; Guarena C; Sacchetti C; Coppo R; Quarello F; Cerutti F
    Acta Paediatr Scand; 1990 Dec; 79(12):1199-203. PubMed ID: 2085107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients.
    Turner ST; Boerwinkle E; Johnson M; Richelson E; Sing CF
    Hypertension; 1987 Jan; 9(1):24-34. PubMed ID: 2432010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte sodium-lithium countertransport in non-modulating offspring and essential hypertensive individuals: response to enalapril.
    Sánchez RA; Giménez MI; Migliorini M; Giannone C; Ramírez AJ; Weder AB
    Hypertension; 1997 Jul; 30(1 Pt 1):99-105. PubMed ID: 9231828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
    Giordano M; Castellino P; Solini A; Canessa ML; DeFronzo RA
    Metabolism; 1997 Nov; 46(11):1316-23. PubMed ID: 9361692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
    Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
    Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-lithium countertransport and systolic blood pressure response to exercise.
    McDonald AM; Liao YL; Trevisan M; Dyer A; Gosch FC; Stamler R; Stamler J
    J Hypertens; 1990 Feb; 8(2):129-37. PubMed ID: 2162875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal sodium-lithium countertransport kinetics in immunoglobulin A nephropathy patients and the families: association with hypertension.
    Ho KL; Rutherford PA; Thomas TH; Wilkinson R
    Am J Kidney Dis; 1996 Mar; 27(3):334-40. PubMed ID: 8604701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of physical work capacity, blood pressure and other hypertension risk factors with the rate of erythrocyte Na/Li countertransport].
    Kocharov AM; Britov AN; Kobal' AM; Grishenkov EA
    Kardiologiia; 1992 Jun; 32(6):30-1. PubMed ID: 1405288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between altered Na+--K+ cotransport and Na+--Li+ countertransport in the erythrocytes of 'essential' hypertensive patients.
    Cusi D; Barlassina C; Ferrandi M; Palazzi P; Celega E; Bianchi G
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():33s-36s. PubMed ID: 7318333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.